Singapore, Singapore, Sep 15, 2024 – XinKailian Biotechnology, a leading player in the nutraceutical industry, is excited to announce the launch of its GMP-certified Ubiquinol (Reduced Coenzyme Q10) product. This product boasts full independent intellectual property rights and comprehensive system certification, meeting USP43 standards. A thorough “Freedom to Operate” (FTO) analysis, addressing industry concerns regarding patent risks, ensures customers can confidently use XinKailian’s Ubiquinol. The product will be unveiled at Vitafoods Asia in 2024.
Comprehensive “Freedom to Operate” Analysis Addresses Patent Concerns
The nutraceutical industry faces growing concerns regarding patent infringement lawsuits, particularly from Kaneka. XinKailian Biotechnology has conducted a thorough FTO analysis to alleviate these concerns. Out of 598 patents reviewed, 62 were deemed relevant. Of these, 16 were classified as low-risk, and 46 were risk-free. No patents were identified as high or medium-risk. This rigorous evaluation, carried out by Unitalen Attorneys At Law and reviewed by U.S. counsel Kilpatrick Townsend & Stockton LLP, provides businesses with the confidence to adopt XinKailian’s Ubiquinol without fear of legal repercussions.
Commitment to Quality Through Advanced Production Techniques
XinKailian’s Ubiquinol is manufactured using advanced techniques to ensure high purity and effectiveness. The CoQ10 raw material is sourced from natural fermentation processes, ensuring premium quality. Furthermore, mild reaction conditions and ultra-low temperature processing are employed to preserve the biological activity of Ubiquinol, enhancing absorption and stability. XinKailian’s commitment to innovation reflects its dedication to delivering high-quality products in the competitive nutraceutical market.
Global Market Readiness with GMP-Certified Ubiquinol
XinKailian Biotechnology is fully equipped to meet global demand, with fully operational facilities adhering to Good Manufacturing Practices (GMP). The company offers competitively priced products, enabling businesses to maintain the highest quality standards while improving profit margins.
Meet Us at Vitafoods Asia 2024
XinKailian Biotechnology will be showcasing its new GMP-certified Ubiquinol at Vitafoods Asia 2024, taking place from September 18-20 at the Queen Sirikit National Convention Center in Bangkok. Attendees are invited to visit booth S10, located at the Yili Chuanning Biotech booth. As a partner of the Kelun Group, one of China’s top three pharmaceutical manufacturers, XinKailian is eager to present this innovative product and its entry into the nutraceutical market.
About XinKailian Biotechnology
XinKailian Biotechnology specializes in producing high-quality Ubiquinol, a vital ingredient for cardiovascular health, neuroprotection, and anti-aging applications. The company’s commitment to GMP certification and USP43 compliance ensures its products meet the highest industry standards for safety, effectiveness, and quality.
For more information, visit XinKailian Biotechnology at Vitafoods Asia 2024 or .
Media Contact
XinKailian Biotechnology
+86 18058818015
Source :XinKailian Biotechnology